Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
97 participants
INTERVENTIONAL
2013-05-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin and the Processing of Social Stress-Associated Chemosignals
NCT03265899
Effects of Oxytocin on Emotion Recognition and Response Inhibition
NCT02350946
Oxytocin and Emotion Recognition
NCT01216605
Oxytocin and Social Cognition
NCT01606462
Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences
NCT03335085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The rationale of the study is to examine direct effects of OXT to processing and learning of emotional and social values in humans.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxytocin
Oxytocin: Syntocinon-Spray, Novartis
intranasal administration, 24 IU oxytocin; ; 3 puffs per nostril, each with 4 IU OXT
Oxytocin
Placebo
Placebo nasal spray
Oxytocin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Current or past physical illness
* Psychoactive medication
* Tobacco smokers
* MRI contraindication
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bonn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rene Hurlemann
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OXT-FC-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.